Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Cardiovascular Biomarkers for the Prediction of Adverse Cardiovascular Events and Mortality in Patients with Cancer

Florian Moik, Simon Kraler, Fabrizio Montecucco, Luca Liberale, Stephan Nopp, Cornelia Englisch, Tetiana Lapikova-Bryhinska, Alexander Akhmedov, Arnold von Eckardstein, Florian A. Wenzl, Ingrid Pabinger, Thomas F. Lüscher, Cihan Ay

Blood (2022) 140 (Supplement 1): 1255–1256.

https://doi.org/10.1182/blood-2022-163287

Published: 2022

Journal Articles

Early Dynamics of C-Reactive Protein Predict Risk of Venous Thromboembolism in Patients with Cancer Treated with Immune Checkpoint Inhibitors

Florian Moik, Jakob Riedl, Dominik Barth, Wei-Shin Evelyn Chan, Sarah Wiedemann, Christoph Höller, Thorsten Fuereder, Philipp Jost, Ingrid Pabinger, Matthias Preusser, Cihan Ay

Blood (2022) 140 (Supplement 1): 1250–1251.

https://doi.org/10.1182/blood-2022-160087

Published: 2022

Journal Articles

Impact of ABO Blood Group Type on Risk of Venous Thromboembolism in Patients with Cancer

Cornelia Englisch, Florian Moik, Stephan Nopp, Markus Raderer, Ingrid Pabinger, Cihan Ay

Blood (2021) 138 (Supplement 1): 2119.

https://doi.org/10.1182/blood-2021-145713

Published: 2021

Journal Articles

Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy

Florian Moik, Wei-Shin Evelyn Chan, Sarah Wiedemann, Christoph Hoeller, Felix Tuchmann, Marie-Bernadette Aretin, Thorsten Fuereder, Sabine Zöchbauer-Müller, Matthias Preusser, Ingrid Pabinger, Cihan Ay

Blood (2021) 137 (12): 1669–1678.

https://doi.org/10.1182/blood.2020007878

Published: 2021

Includes: Supplemental data

Journal Articles

Biomarkers of Haemostasis and Occurrence of Venous Thromboembolism Are Associated with Disease Progression and Poor Prognosis in Patients with Pancreatic Cancer

Florian Moik, MD, Gerald Prager, MD, Sarah Wiedemann, Florian Posch, MD MSc, PhD, Ingrid Pabinger, MD, Cihan Ay, MD

Blood (2020) 136 (Supplement 1): 7–8.

https://doi.org/10.1182/blood-2020-141239

Published: 2020

NARROW

Cardiovascular Biomarkers for the Prediction of Adverse Cardiovascular Events and Mortality in Patients with Cancer

Early Dynamics of C-Reactive Protein Predict Risk of Venous Thromboembolism in Patients with Cancer Treated with Immune Checkpoint Inhibitors

Impact of ABO Blood Group Type on Risk of Venous Thromboembolism in Patients with Cancer

Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy

Biomarkers of Haemostasis and Occurrence of Venous Thromboembolism Are Associated with Disease Progression and Poor Prognosis in Patients with Pancreatic Cancer

Email alerts

ASH Publications

American Society of Hematology

Cardiovascular Biomarkers for the Prediction of Adverse Cardiovascular Events and Mortality in Patients with Cancer

Early Dynamics of C-Reactive Protein Predict Risk of Venous Thromboembolism in Patients with Cancer Treated with Immune Checkpoint Inhibitors

Impact of ABO Blood Group Type on Risk of Venous Thromboembolism in Patients with Cancer

Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy

Biomarkers of Haemostasis and Occurrence of Venous Thromboembolism Are Associated with Disease Progression and Poor Prognosis in Patients with Pancreatic Cancer

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only